Nofafer Human Antivaricella Zoster Virus Immunoglobulin M Enzyme Immunoassay Set - Taiwan Registration dcc7140e2ab1b6e9272981f6f305734e
Access comprehensive regulatory information for Nofafer Human Antivaricella Zoster Virus Immunoglobulin M Enzyme Immunoassay Set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number dcc7140e2ab1b6e9272981f6f305734e and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Enzyme immunoassay was used to legally detect immunoglobulin M classified antibodies against human varicella zoster virus in human serum.
C Immunology and microbiology
C.3900 Varicella Disease Poison Serum Trial
import
Dates and Status
Aug 11, 2006
Aug 11, 2026